G M Hambraeus, C E Mercke. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Esophageal Neoplasms/mortalityEsophageal Neoplasms/therapyHumansSplenectomy/adverse effectsTime Factors
Year: 1979 PMID: 85225 DOI: 10.1016/s0140-6736(79)91067-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321